TY - JOUR
T1 - Impact of the COVID-19 Pandemic on Breast Cancer Screening and Operative Treatment
AU - Cairns, Ashley
AU - Jones, V. Morgan
AU - Cronin, Kelly
AU - Yocobozzi, Margaret
AU - Howard, Clifford
AU - Lesko, Nadja
AU - Chiba, Akiko
AU - Howard-McNatt, Marissa
N1 - Publisher Copyright:
© The Author(s) 2022.
PY - 2022/6
Y1 - 2022/6
N2 - Introduction: The COVID-19 pandemic has impacted many areas of health care and had a significant impact on care delivery, including breast cancer. Methods: To better understand the changes to detection and treatment of breast cancer at our institution, we analyzed mammogram rates (screening and diagnostic) and breast cancer operations in 2019-2020. Mammography rates were calculated using county level census data for eligible women (Z-test). For breast cancer staging, a stage severity score was analyzed with a Mann-Whitney U-test (two-tail, P <.05) with proportions derived from WFBH operative volume quarterly reports. Results: Data revealed a relative decline from 2019 to 2020 in breast cancer screening. Screening mammograms decreased by 44% or 1558 fewer screening mammograms (Z = 4.75, P <.00001) and by 21% or 771 fewer for diagnostic mammograms (Z = 2.16, P =.03). With regards to breast cancer operations, we did not identify a statistically significant difference in number of new breast cancer operations at WFBH with 340 cases in 2020 as compared to 384 cases in 2019 (P =.9905). We compared a breast cancer severity score (weighted by stage at time of operation), which did not reveal statistically significant difference in clinical stage of breast cancer at time of operation (P =.71, U = 28). Conclusion: Mammography was impacted more than breast surgery cases by the COVID-19 pandemic. More data needs to be collected to evaluate future morbidity and mortality related to breast cancer operations and persistent disparities related to delay in breast cancer care due to COVID-19.
AB - Introduction: The COVID-19 pandemic has impacted many areas of health care and had a significant impact on care delivery, including breast cancer. Methods: To better understand the changes to detection and treatment of breast cancer at our institution, we analyzed mammogram rates (screening and diagnostic) and breast cancer operations in 2019-2020. Mammography rates were calculated using county level census data for eligible women (Z-test). For breast cancer staging, a stage severity score was analyzed with a Mann-Whitney U-test (two-tail, P <.05) with proportions derived from WFBH operative volume quarterly reports. Results: Data revealed a relative decline from 2019 to 2020 in breast cancer screening. Screening mammograms decreased by 44% or 1558 fewer screening mammograms (Z = 4.75, P <.00001) and by 21% or 771 fewer for diagnostic mammograms (Z = 2.16, P =.03). With regards to breast cancer operations, we did not identify a statistically significant difference in number of new breast cancer operations at WFBH with 340 cases in 2020 as compared to 384 cases in 2019 (P =.9905). We compared a breast cancer severity score (weighted by stage at time of operation), which did not reveal statistically significant difference in clinical stage of breast cancer at time of operation (P =.71, U = 28). Conclusion: Mammography was impacted more than breast surgery cases by the COVID-19 pandemic. More data needs to be collected to evaluate future morbidity and mortality related to breast cancer operations and persistent disparities related to delay in breast cancer care due to COVID-19.
UR - https://www.scopus.com/pages/publications/85129240595
UR - https://www.scopus.com/inward/citedby.url?scp=85129240595&partnerID=8YFLogxK
U2 - 10.1177/00031348221087920
DO - 10.1177/00031348221087920
M3 - Article
C2 - 35417262
AN - SCOPUS:85129240595
SN - 0003-1348
VL - 88
SP - 1051
EP - 1053
JO - American Surgeon
JF - American Surgeon
IS - 6
ER -
